Mid Cap Most Volatile: Centrais Eletricas Brasileiras SA (NYSE:EBR), Vipshop Holdings (NYSE:VIPS), Criteo SA (NASDAQ:CRTO), Intercept Pharmaceuticals (NASDAQ:ICPT)

Centrais Eletricas Brasileiras SA (NYSE:EBR) is a Brazil-based holding company engaged in the electric power generation, transmission and distribution. Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR) shares after opening at $2.40 moved to $2.65 on last trade day and at the end of the day closed at $2.48. Company price to sales ratio in past twelve months was calculated as 0.22 and price to cash ratio as -. Centrais Eletricas Brasileiras SA (ADR) (NYSE:EBR) showed a positive weekly performance of 13.76%.

Vipshop Holdings Ltd (NASDAQ:VIPS) was upgraded by investment analysts at Wall Street Renegade from an “equal weight” rating to an “overweight” rating in a note issued to investors on Tuesday, American Banking News reports. The firm currently has a $200.00 price target on the stock, up from their previous price target of $125.00. Vipshop Holdings Ltd – ADR (NYSE:VIPS) shares fell -6.78% in last trading session and ended the day on $140.37. VIPS return on equity ratio is recorded as 19.60% and its return on assets is 5.90%. Vipshop Holdings Ltd – ADR (NYSE:VIPS) yearly performance is 379.08%.

Criteo S.A. (NASDAQ:CRTO) announced on march 17 that it has commenced a public offering of 5,250,000 American Depository Shares, or ADSs, each representing one of Criteo’s ordinary shares. Criteo SA (ADR) (NASDAQ:CRTO) shares moved down -7.39% in last trading session and was closed at $45.50, while trading in range of $44.25 – $49.15. Criteo SA (ADR) (NASDAQ:CRTO) year to date (YTD) performance is 33.04%.

Equities researchers at Needham & Company boosted their target price on shares of Intercept Pharmaceuticals (NASDAQ:ICPT) from $320.00 to $500.00 in a research report issued on Tuesday, American Banking News reports. The firm currently has a “buy” rating on the stock. Needham & Company’s price objective would suggest a potential upside of 13.91% from the stock’s previous close. Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) weekly performance is -6.49%. On last trading day company shares ended up $418.91. Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) distance from 50-day simple moving average (SMA50) is 19.33%. Analysts mean target price for the company is $525.86.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *